Haleon rejects Zantac indemnification requests from GSK, Pfizer

Haleon on Tuesday said it had notified GSK and Pfizer that it had rejected their requests for indemnification in relation to U.S.-based litigation over the heartburn drug, Zantac. ... | September 20, 2022

Related Keywords

United States ,London ,City Of ,United Kingdom ,Natalie Grover ,Pfizer ,Boehringer Ingelheim ,Louise Heavens ,Gsk Plc Stock Exchange ,News ,Information ,Press Release ,Xaleon ,N ,Tuesday ,Aid ,It ,Sad ,Cotified ,Mask ,End ,Hat ,Ejected ,Their ,Requests ,Or ,Indemnification ,Relation ,O ,Litigation ,Dover ,The ,Eartburn Gsk Gb00bn7swp63 ,